These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1638 related items for PubMed ID: 29930468

  • 1. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ, Li YT, Wu WR, Shi D, Fang DQ, Yang LY, Bian XY, Wu JJ, Wang Q, Jiang XW, Peng CG, Ye WC, Xia PC, Li LJ.
    World J Gastroenterol; 2018 Jun 21; 24(23):2468-2481. PubMed ID: 29930468
    [Abstract] [Full Text] [Related]

  • 2. A methionine-choline-deficient diet induces nonalcoholic steatohepatitis and alters the lipidome, metabolome, and gut microbiome profile in the C57BL/6J mouse.
    Gautam J, Aggarwal H, Kumari D, Gupta SK, Kumar Y, Dikshit M.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Dec 21; 1869(8):159545. PubMed ID: 39089643
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rifaximin alleviates MCD diet-induced NASH in mice by restoring the gut microbiota and intestinal barrier.
    Shu YY, Hu LL, Ye J, Yang L, Jin Y.
    Life Sci; 2024 Nov 15; 357():123095. PubMed ID: 39368771
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline-Deficient (MCD) Diet-induced Nonalcoholic Steatohepatitis (NASH) Mice.
    Xiong F, Zheng Z, Xiao L, Su C, Chen J, Gu X, Tang J, Zhao Y, Luo H, Zha L.
    Mol Nutr Food Res; 2021 Jul 15; 65(14):e2100067. PubMed ID: 34047448
    [Abstract] [Full Text] [Related]

  • 8. Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels.
    Ye J, Lv L, Wu W, Li Y, Shi D, Fang D, Guo F, Jiang H, Yan R, Ye W, Li L.
    Front Microbiol; 2018 Jul 15; 9():1967. PubMed ID: 30186272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis.
    Yang Z, Xia Q, Lu D, Yue H, Zhang J, Li Y, Zhang B, Li X, Cao M.
    Aging (Albany NY); 2020 Nov 08; 12(21):21660-21673. PubMed ID: 33168782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
    Lv S, Zhang Z, Su X, Li W, Wang X, Pan B, Li H, Zhang H, Wang Y.
    Front Endocrinol (Lausanne); 2022 Nov 08; 13():1106875. PubMed ID: 36743916
    [Abstract] [Full Text] [Related]

  • 13. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
    Lin D, Sun Q, Liu Z, Pan J, Zhu J, Wang S, Jia S, Zheng M, Li X, Gong F.
    Free Radic Biol Med; 2023 Feb 01; 195():199-218. PubMed ID: 36586452
    [Abstract] [Full Text] [Related]

  • 14. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.
    Machado MV, Michelotti GA, Xie G, Almeida Pereira T, Boursier J, Bohnic B, Guy CD, Diehl AM.
    PLoS One; 2015 Feb 01; 10(5):e0127991. PubMed ID: 26017539
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis.
    Matsumoto K, Ichimura M, Tsuneyama K, Moritoki Y, Tsunashima H, Omagari K, Hara M, Yasuda I, Miyakawa H, Kikuchi K.
    PLoS One; 2017 Feb 01; 12(6):e0175406. PubMed ID: 28632732
    [Abstract] [Full Text] [Related]

  • 17. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice.
    Rubio C, Puerto M, García-Rodríquez JJ, Lu VB, García-Martínez I, Alén R, Sanmartín-Salinas P, Toledo-Lobo MV, Saiz J, Ruperez J, Barbas C, Menchén L, Gribble FM, Reimann F, Guijarro LG, Carrascosa JM, Valverde ÁM.
    Mol Metab; 2020 May 01; 35():100954. PubMed ID: 32244182
    [Abstract] [Full Text] [Related]

  • 18. Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway.
    Li C, Zhou W, Li M, Shu X, Zhang L, Ji G.
    Biomed Pharmacother; 2021 Jul 01; 139():111587. PubMed ID: 33865013
    [Abstract] [Full Text] [Related]

  • 19. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
    Ding Y, Sun X, Chen Y, Deng Y, Qian K.
    Eur J Pharmacol; 2015 Aug 15; 761():405-12. PubMed ID: 25967348
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 82.